BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24131912)

  • 21. [Infliximab-induced psoriasis in an adolescent with ulcerative colitis].
    García Morin M; González Ruiz De León E; Tolín Hernani M; Sánchez Sánchez C
    An Pediatr (Barc); 2014 Jan; 80(1):e18-9. PubMed ID: 22475462
    [No Abstract]   [Full Text] [Related]  

  • 22. Development of alopecia areata universalis in a patient receiving adalimumab.
    Garcia Bartels N; Lee HH; Worm M; Burmester GR; Sterry W; Blume-Peytavi U
    Arch Dermatol; 2006 Dec; 142(12):1654-5. PubMed ID: 17179003
    [No Abstract]   [Full Text] [Related]  

  • 23. [Anti-TNF alfa therapy in ankylosing spondylitis].
    Cravo AR; Tavares V; Da Silva JC
    Acta Med Port; 2006; 19(2):141-50. PubMed ID: 17187716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis.
    Dang LJ; Lubel JS; Gunatheesan S; Hosking P; Su J
    Australas J Dermatol; 2014 Feb; 55(1):75-9. PubMed ID: 23651182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Alopecia areata under ipilimumab].
    Amini-Adle M; Dalle S
    Ann Dermatol Venereol; 2018; 145(6-7):465-466. PubMed ID: 29653853
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-pulsed Nd:YAG laser in the treatment of facial hypertrichosis during topical minoxidil therapy.
    Benmously Mlika R; Ben Hamida M; Hammami H; Dorbani Ben Thabet I; Rouatbi M; Mokhtar I
    J Cosmet Laser Ther; 2013 Aug; 15(4):217-8. PubMed ID: 23463948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biologic agents and alopecia areata.
    Katoulis AC; Alevizou A; Bozi E; Georgala S; Mistidou M; Kalogeromitros D; Stavrianeas NG
    Dermatology; 2009; 218(2):184-5. PubMed ID: 19018127
    [No Abstract]   [Full Text] [Related]  

  • 28. Hair transplantation for therapy-resistant alopecia areata of the eyebrows: is it the right choice?
    Civaş E; Aksoy B; Aksoy HM; Eski M; Yucel K
    J Dermatol; 2010 Sep; 37(9):823-6. PubMed ID: 20883369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffuse hair loss following anti-programmed cell death-1 antibody treatment: a case report with immunohistochemical analysis.
    Komatsu-Fujii T; Otsuka A; Ishida Y; Kaku Y; Yamashita C; Hata A; Kataoka T; Honda T; Kabashima K
    Eur J Dermatol; 2019 Jun; 29(3):326-327. PubMed ID: 31389791
    [No Abstract]   [Full Text] [Related]  

  • 30. Case of alopecia areata during dupilumab treatment for atopic dermatitis.
    Kanda N; Koto M; Hoashi T; Saeki H
    J Dermatol; 2019 Sep; 46(9):e332-e333. PubMed ID: 30942915
    [No Abstract]   [Full Text] [Related]  

  • 31. Alopecia associated with zidovudine therapy.
    Geletko SM; Segarra M; Mikolich DJ
    Pharmacotherapy; 1996; 16(1):79-81. PubMed ID: 8700796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence of alopecia areata in a patient receiving etanercept injections.
    Posten W; Swan J
    Arch Dermatol; 2005 Jun; 141(6):759-60. PubMed ID: 15967923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alopecia Areata in Severe Atopic Dermatitis Treated With Dupilumab.
    Barroso-García B; Rial MJ; Molina A; Sastre J
    J Investig Allergol Clin Immunol; 2018 Dec; 28(6):420-421. PubMed ID: 30530389
    [No Abstract]   [Full Text] [Related]  

  • 34. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
    Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
    Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alopecia Areata After Treatment with Dupilumab.
    Yazdanyar S; Jemec GBE
    Dermatitis; 2019; 30(2):175-176. PubMed ID: 30829800
    [No Abstract]   [Full Text] [Related]  

  • 36. Alopecia areata as another immune-mediated disease developed in patients treated with tumour necrosis factor-α blocker agents: Report of five cases and review of the literature.
    Ferran M; Calvet J; Almirall M; Pujol RM; Maymó J
    J Eur Acad Dermatol Venereol; 2011 Apr; 25(4):479-84. PubMed ID: 20586836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alopecia areata during treatment with adalimumab: therapy with an alternative TNF-alpha inhibitor is possible.
    Zschoche C; Bidier M; Hadaschik E
    J Dtsch Dermatol Ges; 2013 May; 11(5):450-3. PubMed ID: 23279686
    [No Abstract]   [Full Text] [Related]  

  • 38. Kawasaki disease and alopecia areata: coincidence or a true association?
    Krishnamurthy S; Chandrashekar L; Mondal N
    Pediatr Dermatol; 2012; 29(4):532-4. PubMed ID: 21906152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psoriatic alopecia/alopecia areata-like reactions secondary to anti-tumor necrosis factor-α therapy: a novel cause of noncicatricial alopecia.
    Doyle LA; Sperling LC; Baksh S; Lackey J; Thomas B; Vleugels RA; Qureshi AA; Velazquez EF
    Am J Dermatopathol; 2011 Apr; 33(2):161-6. PubMed ID: 21317611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia: report of five cases and review of the literature.
    Osório F; Magro F; Lisboa C; Lopes S; Macedo G; Bettencourt H; Azevedo F; Magina S
    Dermatology; 2012; 225(2):163-7. PubMed ID: 23052429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.